Blackstone’s Life Sciences group just added another sizable piece to its growing portfolio with the purchase of Japanese company Takeda Consumer Healthcare (TCHC) for $2.3 billion from . . .
Continue Reading With a Free Trial
Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.
Already a subscriber? Log in.